The European Society for Hemapheresis - short ESFH - was founded in 1984 with the aim of gathering European physicians, scientists, and allied health personnel working in the field of Hemapheresis with a vision to improve donor and patient care. The mission of ESFH is to advance knowledge in apheresis techniques through education, to consolidate and spread proven methods, and to open new paths in the collection of blood cells and treatment of diseases by apheresis.

Learn More

From the literature:

UPDATE

Upcoming Webinar: Thursday, September 21, 2023

Therp announs sept 2023

Link forRegistration

https://event.on24.com/wcc/r/4304283/D63DD2581B9CCA010AEAA07F7B831ECE

 

PREVIOUS

The European Society for Hemapheresis is happy to host, in collaborationwith
Terumo Blood and Cell technologies, an update on CAR-T with two
experts from the
Hospital Clínic of Barcelona in Spain.  
CAR-T Webinar
Wednesday, February 22, 2023,  3 pm to 4:30 pm (GMT+1)

M.Lozano  Mononuclear cell collection for CAR-T therapies
Dr. Miquel Lozano 

,
j.Delgado
Novel applications of CAR-T therapies
Dr. Julio Delgado

 

 

Previous ESFH Congresses

ESFH 22nd  CONGRESS
 held as ahybrid joint meeting of theTurkish Hematology Society, WAA and ESFH
2022 September 14th – 17th
Istanbul, Turkey

ESFH 21th Congress
2021,May 26th - 27th Digital (rescheduled)

ESFH 20th Congress  2018
13th/14th June 2018 Hospital La Fe, Valencia, Spain

 WebinarHow to optimize blood transfusion treatment outcomes for SCD patients?”

 

Recently an interesting investigation was published in Vox Sanguinis concerning in vitro evaluation of buffy coat derived granulocytes for the...
In this paper, the group from Pamplona shows data of stem cell mobilization with filgrastim (G-CSF) in 36 healthy family donors, of which 18...
In this paper the authors reviewed more than 50.000 extracorporeal procedures in 7.142 patients regarding incidence and severity of apheresis...